Project Grant R01AG089522
Award Date
8/15/24
Completion Date
4/30/29
Dollars Obligated
$2.2M
Federal Agency
National Institute on Aging
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Indianapolis, IN 46202, USA
Similar Awards
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $1,592,854 in funding to the University of Illinois to conduct research on tau protein conformation and its role in neurodegenerative diseases like Alzheimer's disease. The key objectives are to: 1) define the effects of tau post-translational modifications on tau function and pathology, 2) determine the role of disease-related tau forms in sporadic and inherited tauopathies, 3) identify...
This $784,596 Project Grant awarded by the National Institute on Aging (CFDA 93.866 - Aging Research) to Northeastern University supports a comprehensive and cell type-specific proteogenomic profiling study of aberrant and mis-processed proteins in Alzheimer's disease (AD) and tauopathy models. The goal is to improve understanding of AD's causes and identify new therapeutic targets by globally profiling disease-associated proteins with amino acid substitutions, alternative isoforms,...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) to the Seattle Institute for Biomedical and Clinical Research will provide $1,709,482 from August 1, 2024 to April 30, 2029 to investigate how the SUT-6/NIPP1 protein regulates pathological tau in Alzheimer's disease and other neurodegenerative "tauopathies." The project aims to define the functions of SUT-6/NIPP1 important for suppressing tau toxicity, determine downstream mediators of...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $437,250 to the University of California, San Diego (UCSD) to develop new imaging tools to study the form and function of tau protein, which is associated with Alzheimer's disease. The award will fund the creation of a peptide-based probe that uses aggregation-induced emission (AIE) to directly measure tau protein as it transitions from a soluble state to liquid-liquid phase separation...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $776,051 to The Washington University in St. Louis to conduct research on staging primary tauopathies using tau proteoforms. The goal is to define which tau proteoforms change during disease progression in both familial and sporadic primary tauopathies, such as progressive supranuclear palsy, corticobasal degeneration, and frontotemporal lobar degeneration. This research aims to facilitate...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $146,922 to The Johns Hopkins University to investigate physiological pathways that regulate the microtubule-associated protein tau (tau) and their potential implications for Alzheimer's disease and related dementias. The research aims to utilize the PS19 mouse model to examine how the loss of the enzyme glycerophosphodiester phosphodiesterase 2 (GDE2) affects the onset and progression of...
This $717,709 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) supports research to advance the understanding of tau protein aggregation and propagation in Alzheimer's disease (AD) and frontotemporal dementia (FTD). The awardee, Weill Medical College of Cornell University, will utilize advanced proteomic techniques, including affinity purification mass spectrometry and transcriptomic profiling, to map the molecular mechanisms underlying tau pathology in...
This $1,147,300 Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) will support a research study at Wayne State University investigating the role of local protein synthesis in tau pathology and neurodegeneration associated with Alzheimer's disease. The project aims to examine how pathogenic forms of the tau protein specifically interfere with dendritic protein synthesis, a key process underlying synaptic function and plasticity. By leveraging animal...
This federal Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) provides $594,041 to the University of Southern California to conduct research on the impact of ethnicity on the utility of plasma amyloid and tau biomarkers to predict Alzheimer's disease. The project aims to comprehensively measure phosphorylated tau species (p-tau217) in plasma samples from the Health and Aging Brain Study-Health Disparities (HABS-HD) cohort, which includes Hispanic,...
The National Institute on Aging (NIA) awarded a $7,249,563 Project Grant under the Aging Research federal grant program (CFDA 93.866) to the Regents of the University of California, San Francisco (UCSF). This 3-year award, starting on Aug 1, 2023, will support research to characterize the structural properties and variability of tau protein aggregation in different brain cell types and at different disease stages of Alzheimer's and related dementias (ADRD). The project aims to develop new...